Top

Published in:

01-11-2014 | Radiotherapy

Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma

Authors: Yi-Jun Wang, Ting-Ting Han, Jun-Xia Xue, Dong-Shu Chang, Hong-Qi Li, Ping Li, Ji-Dong Wang, Ying-Jie Wang, Ting-Yi Xia

Published in: La radiologia medica | Issue 11/2014

Abstract

Purpose

To preliminarily evaluate the feasibility, therapeutic effect and toxicity of stereotactic gamma-ray body radiation therapy (γ-SBRT) for asynchronous bilateral renal cell carcinoma (bRCC).

Materials and methods

A retrospective analysis was performed on the clinical data of nine patients with asynchronous bRCC who were unable to undergo surgery and received γ-SBRT between February 2002 and May 2012. A total dose of 36–51 Gy was delivered to the 50 % isodose line covering the planning target volume at 3–5 Gy/fraction, whereas a total dose of 60–85 Gy was delivered at 5–7 Gy/fraction to the gross target volume. The local control rate (LC) and overall survival rate (OS) were calculated using the Kaplan–Meier method.

Results

Patient follow-up ended in March 2013 and the follow-up rate was 100 %. Of the nine patients, none presented with complete remission and five (55.6 %) achieved partial remission. The objective response rate was 55.6 %. The 1-, 3- and 5-year LC rates were 64.8, 43.2 and 43.2 %, respectively. The 1-, 3- and 5-year OS rates were 66.7, 53.3 and 35.6 %, respectively. Four (44.4 %) patients had an acute radiation reaction; there were two cases of grade I leukocytopenia and two cases of grade I gastrointestinal reactions. Late radiation-induced toxicity consisted of grade II gastrointestinal reactions in two patients.

Conclusion

Stereotactic gamma-ray body radiation therapy was found to be safe and effective in the treatment of asynchronous bRCC. Improved prognosis will require individualised treatment and a combination of multiple therapeutic approaches; this will be a primary research trend in the future.

Cairns P (2010) Renal cell carcinoma. Cancer Biomark 9:461–473PubMed

Robson CJ (1963) Radical nephrectomy for renal cell carcinoma. J Urol 89:37–42PubMed

McKiernan J, Simmons R, Katz J, Russo P (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59:816–820PubMedCrossRef

Xia T, Li H, Sun Q et al (2006) Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:117–125PubMedCrossRef

Xia T, Li H, Wang Y et al (2007) Clinical outcome of whole body gamma knife therapy inoperable stage I/II non-small-cell lung cancer. Chin J Radiat Oncol 3:91–97

Chang D, Xia T, Li P et al (2009) Clinical outcome of whole body γ-knife for limited pancreatic carcinoma. Chin J Radiat Oncol 18:470–473

Li H, Wang Y, Li P, Wang X et al (2012) Clinical study of stereotactic gamma-ray body radiation therapy for patients with stage I/II non-small-cell lung cancer. Chin J Radiat Oncol 21:321–324

Kondziolka D, Ong JG, Lee JY et al (2009) Gamma knife thalamotomy for essential tremor. J Neurosurg 108:111–117CrossRef

Verheul JB, Hanssens PE, Lie ST et al (2010) Gamma knife surgery for trigeminal neuralgia: a review of 450 consecutive cases. J Neurosurg 113:160–167PubMed

10.

Niu X, Rajanbabu A, Delisle M et al (2013) Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival. J Obstet Gynaecol Can 35:816–822PubMed

11.

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247PubMedCrossRef

12.

Eggener SE, Rubenstein JN, Smith ND et al (2004) Renal tumors in young adults. J Urol 171:106–110PubMedCrossRef

13.

Blute ML, Itano NB, Cheville JC et al (2003) The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol 169:1276–1281PubMedCrossRef

14.

Novick AC, Gephardt G, Guz B et al (1991) Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058–1062PubMedCrossRef

15.

Gong D, Li Z, Wang X et al (2007) Strategy in diagnosis and treatment of bilateral renal cell carcinoma. Chin J Urol 28:585–587

16.

Patel MI, Simmons R, Kattan MW et al (2003) Long-term follow-up of bilateral sporadic renal tumors. Urology 61:921–925PubMedCrossRef

17.

Kume H, Oda H, Nakatsuru Y et al (2000) Genetic identification of bilateral primary or metastatic nonpapillary renal cell carcinoma. BJU Int 86:208–212PubMedCrossRef

18.

Hyman RA, Voges V, Finby N (1973) Bilateral hypernephroma. Am J Roentgenol Radium Ther Nucl Med 117:104–107PubMedCrossRef

Title: Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma
Authors: Yi-Jun Wang
Ting-Ting Han
Jun-Xia Xue
Dong-Shu Chang
Hong-Qi Li
Ping Li
Ji-Dong Wang
Ying-Jie Wang
Ting-Yi Xia
Publication date: 01-11-2014
Publisher: Springer Milan
Published in: La radiologia medica / Issue 11/2014
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI: https://doi.org/10.1007/s11547-014-0402-3

At a glance: The STEP trials

Springer Medicine

Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma

Abstract

Purpose

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2014

C-arm cone-beam computed tomography needle path overlay for percutaneous biopsy of pulmonary nodules

In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage

Dosimetric evaluation of a 256-slice computed tomography scanner

Use of “Time-Out” checklist in interventional radiology procedures as a tool to enhance patient safety

Ct-guided bone biopsy in cancer patients with suspected bone metastases: retrospective review of 308 procedures

A single-centre experience of 200 consecutive unselected patients in percutaneous EVAR